Relationship of Conduction Defects and In-Hospital Outcome after Acute ST Segment Elevation Myocardial Infarction

M S Rahman1, N A Siddique, M Hossain

  • 1Dr Mohammad Shafiqur Rahman, Assistant Professor, Department of Cardiology, Mymensingh Medical College (MMC), Mymensingh, Bangladesh;

Insights

Conduction defects in acute myocardial infarction (MI) increase mortality, especially with anterior MI. Early identification and management are crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Conduction defects are frequent complications of acute myocardial infarction (MI).
  • These defects are linked to increased short- and long-term mortality.
  • The impact of thrombolytic therapy on reducing conduction defects is not well-defined.

Purpose of the Study:

  • To assess the correlation between conduction defects and adverse in-hospital outcomes in patients with acute ST-segment elevation MI.
  • To investigate the prevalence of different types of conduction defects in relation to MI location.
  • To determine the impact of conduction defects on mortality and complications.

Main Methods:

  • A cross-sectional, descriptive observational study of 100 patients with acute ST-segment elevation MI.
  • Patients were divided into two groups: with conduction defects (Group A, n=40) and without (Group B, n=60).
  • Data collected included patient demographics, MI location, type of conduction defect, and in-hospital outcomes.

Main Results:

  • Conduction defects were more common in inferior MI (43.5%) than anterior MI (40.9%).
  • Atrio-ventricular conduction defects were more frequent in inferior MI, while intra-ventricular defects were more common in anterior MI.
  • Complications (65.0% vs 18.3%) and mortality (20.0% vs 3.3%) were significantly higher in patients with conduction defects (p<0.001).
  • Mortality was significantly higher in anterior MI patients with conduction defects (p<0.001).

Conclusions:

  • Conduction defects are common in acute MI and significantly increase in-hospital complications and mortality.
  • The type and location of MI influence the prevalence and type of conduction defects.
  • Conduction defects, particularly in anterior MI, are associated with a substantial increase in mortality.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
35
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
58
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
285
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23